Evaluating the Safety and Efficacy of Asundexian in Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background Thromboembolic events remain a major cause of morbidity and mortality in cardiovascular diseases, particularly myocardial infarction, atrial fibrillation (AF), and ischemic stroke. While standard anticoagulants reduce these events, their use is limited by bleeding risks. Asundexian, a Fac...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Zainab Arif MBBS, Muhammad Ashbar Wadood MBBS, Sania Malahat MBBS, Mehmood Ahmad MBBS, Maliha Khalid MBBS, Saman Adnan MBBS, Erum Siddiqui MBBS, Aminath Waafira MBBS
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SAGE Publishing 2025-07-01
Colecção:	Clinical and Applied Thrombosis/Hemostasis
Acesso em linha:	https://doi.org/10.1177/10760296251365238
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!